BE900874A - NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AS MEDICAMENTS. - Google Patents

NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AS MEDICAMENTS.

Info

Publication number
BE900874A
BE900874A BE1/011127A BE1011127A BE900874A BE 900874 A BE900874 A BE 900874A BE 1/011127 A BE1/011127 A BE 1/011127A BE 1011127 A BE1011127 A BE 1011127A BE 900874 A BE900874 A BE 900874A
Authority
BE
Belgium
Prior art keywords
therapeutics
medicaments
novel
preparation
alkyl group
Prior art date
Application number
BE1/011127A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE900874A publication Critical patent/BE900874A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

L'invention concerne les 1,4-dihydropyridines de formule (I) dans laquelle R1 signifie l'hydrogène ou un groupe cycloalkyle ou alkyle, R2 et R4 signifient l'hydrogène ou un groupe alkyle, R3 signifie l'hydrogène ou un groupe alkyle, NO2, CF3, CN, C00R5, COR6 ou S(O) nR7 où R5, R6 et R7 sont des radicaux variés, n signifie 0, 1 ou 2 et Q signifie un système cyclique condensé complètement insaturé. Ces Composés peuvent etre utilisés comme médicaments, notamment comme antagonistes du calcium.The invention relates to 1,4-dihydropyridines of formula (I) in which R1 signifies hydrogen or a cycloalkyl or alkyl group, R2 and R4 signify hydrogen or an alkyl group, R3 signifies hydrogen or an alkyl group , NO2, CF3, CN, C00R5, COR6 or S (O) nR7 where R5, R6 and R7 are various radicals, n means 0, 1 or 2 and Q means a completely unsaturated condensed ring system. These Compounds can be used as drugs, especially as calcium antagonists.

BE1/011127A 1983-11-01 1984-10-23 NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AS MEDICAMENTS. BE900874A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH589183 1983-11-01
CH589383 1983-11-01
CH589583 1983-11-01
CH357884 1984-07-24
CH358084 1984-07-24

Publications (1)

Publication Number Publication Date
BE900874A true BE900874A (en) 1985-04-23

Family

ID=27509144

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011127A BE900874A (en) 1983-11-01 1984-10-23 NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AS MEDICAMENTS.

Country Status (12)

Country Link
AU (1) AU3486884A (en)
BE (1) BE900874A (en)
DE (1) DE3438884A1 (en)
DK (1) DK517484A (en)
FR (1) FR2554109A1 (en)
GB (1) GB2148895A (en)
IL (1) IL73363A0 (en)
IT (1) IT1199214B (en)
LU (1) LU85621A1 (en)
NL (1) NL8403302A (en)
SE (1) SE8405450L (en)
WO (1) WO1985001940A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420784A1 (en) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 3-NITRO-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
DE2752820A1 (en) * 1977-11-26 1979-05-31 Bayer Ag NEW NITRO-SUBSTITUTED 1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT
DE2949464A1 (en) * 1978-12-18 1980-06-26 Sandoz Ag BENZOXADIAZOLES AND BENZOTHIADIAZOLES, THEIR PRODUCTION AND USE
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
FR2554109A1 (en) 1985-05-03
SE8405450L (en) 1985-06-10
GB2148895A (en) 1985-06-05
IT1199214B (en) 1988-12-30
IT8449079A1 (en) 1986-04-29
AU3486884A (en) 1985-05-09
IT8449079A0 (en) 1984-10-29
DE3438884A1 (en) 1985-05-09
LU85621A1 (en) 1985-07-17
NL8403302A (en) 1985-06-03
IL73363A0 (en) 1985-01-31
WO1985001940A1 (en) 1985-05-09
DK517484D0 (en) 1984-10-30
SE8405450D0 (en) 1984-10-31
DK517484A (en) 1985-05-02
GB8427443D0 (en) 1984-12-05

Similar Documents

Publication Publication Date Title
DE3683823D1 (en) ANTI-HYPERTENSIVE AGENTS CONTAINING 2-ALKYNYLADENOSINE AS ACTIVE INGREDIENTS.
ATE71625T1 (en) IMIDAZOHETEROCYCLIC COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2405934A1 (en) NEWS 4-THIO-2-OXO AZETIDINES USEFUL IN THE SYNTHESIS OF DRUGS
ATE85325T1 (en) CYCLIC ENOLDERIVES, PREPARATION AND APPLICATION.
HUP9901652A2 (en) Use of piperidine-carboxylic acid derivatives for producing pharmaceutical compositions suitable for reducing blood glucose
FR2442845A1 (en) SPIRANIC AMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
BE904796A (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI870589A0 (en) NY FARMACEUTISK SAMMANSAETTNING OCH FOERFARANDE FOER FRAMSTAELLNING AV DEN.
DE69031913D1 (en) ANTIVIRAL AGENTS
FR2388793A1 (en) AZETIDINYL-ACETONITRILES AND -ACETAMIDES, ANTIARRHYTHMIC COMPOSITIONS CONTAINING THESE COMPOUNDS AND USE OF THESE COMPOSITIONS
DK656488D0 (en) LONG-RELEASE PREPARATION CONTAINING 1,4-DIHYDROPYRIDINE COMPOUNDS
BE1002213A5 (en) NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.
FR2361370A1 (en) NEW SUBSTITUTED PYRIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2358382A1 (en) NEW NONAPEPTIDES, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE899937A (en) NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.
ATE12641T1 (en) AZEPININDOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BE900874A (en) NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AS MEDICAMENTS.
FR2447375A1 (en) PROSTAGLANDIN E1 ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE905654A (en) DERIVATIVES OF ARMSTRONG 2-1,2,4-TRIAZOLINE-5-ONE, PROCESS FOR THEIR PREPARATION AND THEIR USES.
BE905397A (en) NOVEL BICYCLIC ALLYL ETHERS, THEIR PREPARATION AND THEIR USE AS ANTI-FUNGAL AND FUNGICIDES.
DE3788149D1 (en) Prostacycline (PGI2) analogs.
FR2378518A1 (en) NEW MEDICINES BASED ON TETRAHYDRODIBENZOPYRANE DERIVATIVES
DE69007356D1 (en) Cyclic tetrapeptide and process for its preparation.
FI870460A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA 5-SUBSTITUERADE OKTAHYDROINDOLIZINDERIVAT OCH VID FOERFARANDET ANVAENDBARA MELLANPRODUKTER.
TNSN87066A1 (en) PROPARGYLOXYBENZENES DERIVATIVES, THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19861031